[On dopan therapy of patients with lymphogranulomatosis, chronic lymphatic leukemia and other systemic blood diseases].
D000970:Antineoplastic Agents / Q000628:therapy*; D006402:Hematologic Diseases; D006689:Hodgkin Disease / Q000628:therapy*; D006801:Humans; D007938:Leukemia; D015451:Leukemia, Lymphocytic, Chronic, B-Cell; D007945:Leukemia, Lymphoid / Q000628:therapy*; D008214:Lymphocytes; D014498:Uracil / Q000031:analogs & derivatives; D014499:Uracil Mustard / Q000031:analogs & derivatives
D000970:Antineoplastic Agents; C006994:chloroethylaminouracil; D014498:Uracil; D014499:Uracil Mustard
ANTINEOPLASTIC AGENTS/therapy; HODGKIN'S DISEASE/therapy; LEUKEMIA, LYMPHOCYTIC/therapy; URACIL/related compounds